-
NASDAQ Stocks Hitting 52-Week Highs (LONG, TECH, ANTH, TSTF)
Tuesday, May 17, 2011 - 10:08am | 139eLong Inc (NASDAQ: LONG) shares surged 35.44% to create a new 52-week high of $22.97. Tencent Holdings Ltd purchased an $84.4 million stake in eLong Inc. Techne Corporation (NASDAQ: TECH) shares jumped 1.22% to create a new 52-week high of $80.80. TECH's trailing-twelve-month operating margin is...
-
Thermo Fisher Scientific Completes Tender Offer for Dionex Corporation
Monday, May 16, 2011 - 8:32am | 143Thermo Fisher Scientific (NYSE: TMO) today announced that it has successfully completed its tender offer for Dionex Corporation (NASDAQ: DNEX), which expired at 7:00 pm, New York City time, on Friday, May 13, 2011. Based on preliminary information from the depositary for the tender, as of the...
-
Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest Operating Margin (LH, DGX, PPDI, CVD)
Monday, May 16, 2011 - 12:42am | 131Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Laboratory Corp. of America Holdings (NYSE: LH) is 20.02%. LH's ROE for the same period is 24.61%. The trailing-twelve-month...
-
Arista Laboratories Purchases Waters NuGenesis Scientific Data Management System to Bring Laboratories into Adherence With Good Laboratory Practices
Friday, May 13, 2011 - 2:00pm | 80Waters Corporation (NYSE: WAT) announced today that Arista Laboratories (Richmond, VA) has purchased the Waters NuGenesis® Scientific Data Management System software in order to become the first such laboratory to offer GLP testing of tobacco products in anticipation of new FDA regulations which...
-
pSivida Announces Resubmission of New Drug Application for ILUVIEN
Friday, May 13, 2011 - 8:37am | 106pSivida Corp. (NASDAQ: PSDV) today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIEN® for the treatment of diabetic macular edema to the U.S. Food and Drug Administration on May 12, 2011 to address questions raised in the...
-
Morgan Stanley Raises PT on Illumina To $84
Friday, May 13, 2011 - 8:24am | 26Morgan Stanley has raised the price target on Illumina (NASDAQ: ILMN) from $78 to $84 and maintains its Outperform rating.
-
Morgan Stanley Increases PT on Illumina to $84, Maintains Overweight (ILMN)
Friday, May 13, 2011 - 8:09am | 94Morgan Stanley increased its price target on Illumina (NASDAQ: ILMN) from $78 to $84. At the same time, it increased its earnings per share estimates for the following three years and left its rating unchanged at Overweight. In a research report published today, Morgan Stanley states, "Our price...
-
Morning Market Movers (BASI, DVOX, QTWW, NSYS)
Thursday, May 12, 2011 - 10:16am | 136Bioanalytical Systems Inc (NASDAQ: BASI) jumped 26.34% to $2.35 at 10:10 am. BASI reported its Q2 net income of $0.10 per share, compared with a loss of $0.25 per share. DynaVox Inc (NASDAQ: DVOX) shares advanced 24.63% to $7.54. DVOX reported a 1.0% y/y increase in its Q3 net sales. Quantum...
-
Jefferies Raises WuXi PharmaTech PT From $20 To $22
Thursday, May 12, 2011 - 8:29am | 23Jefferies is raising its PT on shares of WuXi PharmaTech Inc. (NYSE: WX) from $20 to $22.
-
NASDAQ Stocks Hitting 52-Week Highs (TISA, LMNX, GCOM, ASMI)
Wednesday, May 11, 2011 - 10:07am | 132Top Image Systems Ltd (NASDAQ: TISA) shares surged 49.62% to create a new 52-week high of $2.0050. TISA reported a 167% y/y jump in its Q1 net income. Luminex Corporation (NASDAQ: LMNX) shares jumped 2.50% to create a new 52-week high of $21.52. LMNX reported stronger-than-expected Q1 profit....
-
UPDATE: Auriga Raises PT on Thermo Fisher Scientific to $73 (TMO)
Wednesday, May 11, 2011 - 8:49am | 88Auriga is out with its report today on Thermo Fisher Scientific (NYSE: TMO), raising its PT to $73. In a note to clients, Auriga writes, "Given TMO's solid end market demand, continued margin expansion, strong cash flow and attractive product portfolio, we view TMO's current discount (14x) to the...
-
Morgan Stanley Overweight Rating On WuXi Pharmatech (WX)
Wednesday, May 11, 2011 - 8:08am | 95In a recent report, Morgan Stanley has reiterated an Overweight rating on WuXi Pharmatech (NYSE: WX) after 1Q results show the fundamentals are stronger than ever. In the report, Morgan Stanley said, "We expect large-scale commercial manufacturing commencing in 2011 and solid contribution from...
-
Auriga Raises PT on Thermo Fisher Scientific To $73
Wednesday, May 11, 2011 - 8:05am | 27Auriga USA has raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $73 and maintains its Buy rating.
-
Jefferies & Company Reports on WuXi PharmaTech (WX)
Wednesday, May 11, 2011 - 7:57am | 121Jefferies & Company commented on WuXi PharmaTech (NYSE: WX) in a report released today. In the report, Jefferies was positive in their outlook of the company. Jefferies writes, “WuXi reported 1Q revenue and earnings that slightly exceeded our estimates. The company continues to drive double-...
-
Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest Cash (DGX, PPDI, ALR, CVD)
Wednesday, May 11, 2011 - 2:19am | 134Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of cash. Quest Diagnostics Incorporated (NYSE: DGX) had $994.20 million in total cash and $4.22 billion in total debt for the latest quarter. Pharmaceutical Product Development Inc (NASDAQ:...